Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The study will investigate the effect of PL-56 on albumin leakage and renal function
(glomerular filtration rate) in patients with IgA nephropathy. It will also assess the safety
of treatment with PL-56.